Aminopeptidase activities were identified in extracts of kidney, ovotestis, head ganglia, heart and haemolymph of Aplysia californica. These enzyme preparations hydrolysed [3H][Leu]enkephalin at the Try-l-Gly-2 bond as determined by h.p.l.c. analysis of cleavage products. In all these tissues, enkephalin-degrading aminopeptidase activities were present both in membrane-bound and cytosolic fractions. The bivalent-cation-chelating agent, 1,10-phenanthroline, inhibited kidney membrane aminopeptidase activity with an IC50 of 30 4uM, suggesting that this enzyme is a metalloproteinase. The aminopeptidase inhibitor amastatin was the most potent inhibitor of [Leu]enkephalin degradation (IC50 25 nM) by membrane-bound aminopeptidase, and bacitracin, bestatin and puromycin were about 100-1000 times less potent. In contrast with membrane-bound aminopeptidase, the cytosolic form is sensitive to puromycin. Angiotensin-converting enzyme inhibitor had no effect on [Leu]enkephalin degradation by kidney membranes, while the neutral endopeptidase inhibitors were poor inhibitors of the enzymes in this preparation. The Km values of the aminopeptidase in the kidney membranes and cytosolic fractions for the [Leu]enkephalin substrate were 2.4 and 7.4 ftM respectively. The aminopeptidase present in the kidney membranes also hydrolysed endogenous Phe-Met-Arg-Phe-amide peptide at the Phe-l-Met-2 bond as well as synthetic alanine p-nitroanilide and leucine p-nitroanilide. When used in a competition assay, these substrates inhibited hydrolysis of [3H][Leu]enkephalin, suggesting that the same enzyme degraded all these substrates. Taken together, these results suggest that Aplysia tissues contain both a membrane-bound aminopeptidase related to the mammalian aminopeptidase N and a cytosolic puromycin-sensitive aminopeptidase.
INTRODUCTION
The marine mollusc Aplysia californica is a useful model to study the central nervous system because of the relatively small number and large size of its neurons (Kandel, 1979) . By using molecular-biology techniques, a large number of neuropeptides has been identified from Aplysia neurons [for reviews see DesGroseillers & Scheller (1988) ] and some of the putative peptides derived from the precursor proteins show remarkable sequence similarities to mammalian neuropeptides (Taussig & Scheller, 1986; Wickham & DesGroseillers, 1991) . Secreted neuropeptides can act over short distances within the constrained space of the synapse or travel some distance from their site of release to mediate their physiological functions (Bousfield, 1985) . In contrast with chemical neurotransmitters, which can be degraded and/or recaptured at the synapses, recapture does not seem to be a predominant mechanism for terminating the action of neuropeptides. Peptide neurotransmitters rather appear to be mostly degraded by a broad range of relatively non-specific peptidases (Kenny et al., 1987) . In the mammalian brain, several neuropeptide-degrading enzymes have been identified. These include a dipeptidyl aminopeptidase (EC 3.4.14.1) (Gorenstein & Snyder, 1979; Gorenstein et al., 1981) , an angiotensin-converting enzyme (EC 3.4.15.1) (Erd6s et al., 1979) , a neutral endopeptidase (enkephalinase, EC 3.4.24.11) (Kerr & Kenny, 1984; Malfroy et al., 1978; Sullivan et al., 1978; Schwartz et al., 1981; De La Baume et al., 1983) and an aminopeptidase (EC 3.4.11.2) (Hersh, 1981 (Hersh, , 1985 De La Baume et al., 1983; Hui et al., 1983; Gros et al., 1985; Matsas et al., 1985) . These peptidases are also distributed in many tissues other than the brain. They are integral membrane proteins which possess an active site facing the extracellular space where they are most likely to participate in the metabolism of secreted regulatory peptides. All these peptidases, however, are relatively non-specific and can hydrolyse a wide range of peptides. Conversely each peptide is usually a potential substrate for several proteinases. Thus the physiological role of these peptidases can best be tested by monitoring the pharmacological activity of specific inhibitors.
Selective inhibitors of neutral endopeptidase such as thiorphan (Roques et al., 1980) , kelatorphan (Fournie-Zaluski et al., 1984) and (3-hydroxyaminocarbonyl-2-benzyl-l-oxopropyl)glycine (HACBO-Gly) (Waksman et al., 1985) and of aminopeptidase such as amastatin, bestatin (Umezawa et al., 1976; Aoyagi et al., 1978; Wilkes & Prescott, 1985) , bacitracin and puromycin have been described. Some of them have been shown to protect endogenous enkephalins from degradation (Patey et al., 1981) and thus can induce analgesia (Roques et al., 1980; Zhang et al., 1982; Chaillet et al., 1983; De La Baume et al., 1983) , clearly establishing neutral endopeptidase and aminopeptidase N as physiologically relevant enkephalin-degrading enzymes.
The post-translational regulation of Aplysia neuropeptides, especially their proteolytic degradation and the mechanisms of their inactivation, is still poorly documented. As a first step toward understanding the mechanism of peptide degradation in relation to animal physiology, we began searching for peptidase activity in Aplysia organs. Using well-studied peptide substrates such as [Leu] enkephalin and its analogue [D-Ala2-LeuJenkephalin (Pert et al., 1976; Llorens et al., 1982) , we have investigated the presence of peptidases in kidney, ovotestis, head ganglia, heart and haemolymph of the mollusc Aplysia californica. In addition, Phe-Met-Arg-Phe-amide (FMRFamide) was used to extend these studies to an endogenous Aplysia Vol. 286 967 Abbreviations used: HACBO-Gly (3-hydroxyaminocarbonyl-2-benzyl-1-oxopropyl)glycine; [3HJ[Leulenkephalin, neuropeptide. This peptide was shown to be involved in muscular contraction (Austin etal., 1982; Weiss etal., 1984; Richmond et al., 1986; Cawthorpe & Lukowiak, 1990) and in modulation of the activity of specific neurons (Abrams etal., 1984; Ocorr & Byrne, 1985; Thompson & Ruben, 1988; Ichinose & McAdoo, 1988; S.-Rozsa etal., 1991; Critz etal., 1991 (Bawab etal., 1991 
Animals
Aplysia californica weighing 75-150 g were purchased from Marinus (Long Beach, CA, U.S.A.) and maintained in an aerated recirculating-seawater tank at 15°C for less than 2 weeks before being killed.
Membrane preparations
Tissues from Aplysia californica were dissected out and cut into 5-10mm3 fragments. Tissue fragments (1 g wet weight) were further homogenized at 4°C with Polytron homogenizer in 5 ml of 10 mM-sodium phosphate buffer, pH 7.5, containing 30 mmNaCl, 1 mM-MgCl2 and 0.02 % (w/v) NaN3, using three to five bursts of 10 s each. The homogenate was diluted 5-fold and filtered through nylon gauze. About 25 ml of the homogenate was layered over 10 ml of a 41 % (w/v) solution of sucrose in the homogenization buffer and centrifuged at 95000 g for 1 h at 4°C in a Beckman SW 27 rotor (Maeda et al., 1983 (Crine et al., 1985) . Solubilization and phase separation ofmembrane and cytosolic fractions with Triton X-1 14 were performed as described (Bordier, 1981; Matsas et al., 1985) , with minor modifications. Briefly, membrane and cytosolic fractions (400 ,tg of protein)
were incubated for 2 h with 2% Triton X-114 in Tris/HC1, pH 7.5. The unsolubilized materials were eliminated by centrifugation at 30000 g for 60 min at 4 'C. The supernatant was warmed up to 30 'C and phase separation was completed at 1500 g for 5 min at 30°C . The detergent-rich phase was washed and both phase's were re-extracted as above. The aminopeptidase activity was determined as described above. enkephalin by membranes isolated from Aplysia kidney released a single radioactive metabolite which co-migrated with the free amino acid tyrosine (Fig. 2) . The same result was obtained with the membrane-bound enzyme from ovotestis and head ganglia and with the enzyme found in haemolymph and kidney cytosolic fractions. No other peak was seen at any other position. In order to ensure that the free [3H]tyrosine was really the result of an aminopeptidase activity splitting the Tyr-Gly bond and not the product of progressive degradation by a carboxypeptidase activity, we repeated the reversed-phase h.p.l.c. analysis at various incubation times. As shown in Fig. 2(a) , the first and only metabolite recovered after an incubation period as short as 15 s co-migrates with free tyrosine. As expected for an aminopeptidase activity, this tyrosine peak progressively increased with the reaction time (Figs. 2b and 2c) (Fig. 3) , suggesting that this aminopeptidase activity is due to a metal-binding enzyme.
Metalloproteinase inhibitors were then used to characterize further the enzyme activity present in the kidney membranes. Fig. 3 6 ,UM and 22 /SM respectively. Kelatorphan, which in mammalian tissues completely inhibits enkephalin metabolism as a result of its effect on both aminopeptidase and neutral endopeptidase activities, inhibited 91 % of the Aplysia aminopeptidase activity when used at a concentration of 100 ,UM.
In contrast, neutral endopeptidase inhibitors phosphoramidon, thiorphan and HACBO-Gly inhibited less than 10 % of
[Leu]enkephalin degradation, when used at a concentration of 1 /,M (Table 2) . However, when used at a concentration of 100 /M, up to 50% inhibition could be observed. Considering that these compounds inhibit mammalian neutral endopeptidase with K, in the nanomolar range (Kenny et al., 1987) , this effect observed at high concentrations on the Aplysia enzymic activity is most probably non-specific. Furthermore, h.p.l.c. analysis of the metabolites obtained in the presence of 100 /M showed a The membrane-bound aminopeptidase activity was further studied to determine if the enzyme is an integral or a peripheral membrane protein. Isolated kidney membranes were washed in the presence of 50 mM-Tris/HCl, pH 7.5, either alone or in the presence of 1 M-NaCl. This high-salt concentration has often been used to solubilize peripheral proteins bound to membranes by ionic interactions (Hersh, 1985; Dyer et al., 1990) . After membrane centrifugation, none of the membrane-bound aminopeptidase activity was released into the supernatant (not shown), suggesting that the Aplysia enzyme is an integral membrane protein. To prove this point further, we took advantage of the property of solutions of Triton X-1 14 to separate it into detergent-rich and detergent-poor phases at 30°C (Bordier, 1981) . Membrane and cytosolic fractions were each incubated with Triton X-1 14 and the detergent phases separated at 30°C as described in the Materials and methods section. As seen in Table   3 , 34+2 % of the membrane-bound activity was recovered in the detergent-rich phase, demonstrating that a sizeable proportion of the activity recovered in the membrane fraction corresponds to an integral membrane protein. This membrane-bound activity in Aplysia is largely puromycin-insensitive, suggesting the presence of an enzyme similar to mammalian aminopeptidase N. The enzymic activity recovered in the detergent-poor phase showed the same inhibition profile. When cytosolic fractions were phaseseparated in Triton X-1 14, 82 + 6 % of the enzymic activity was recovered, as expected, in the detergent-poor phase. In contrast with the membrane-bound enzymic activity, this one was inhibited by puromycin, clearly demonstrating that different aminopeptidases are present in the membrane-bound and cytosolic fractions. As control, we have isolated rat kidney membranes and proceeded to the phase separation using Triton X-114 as before: 55+3% and 45+3% of the aminopeptidase activity was recovered in the detergent-rich and detergent-poor phases respectively, and, as in Aplysia, both activities are puromycin-insensitive (Table 3) . This is also consistent with the previous observations that 62 % of the aminopeptidase activity in pig kidney microvillar membranes was recovered in the detergent-rich Triton X-1 14 phase (Matsas etal., 1985) ; however, in brain synaptic membranes, only 5.5 % of the aminopeptidase activity, which corresponds to aminopeptidase N, was recovered in the detergent-rich phase.
Degradation of Aplysia endogenous FMRFamide peptide
To analyse the peptide specificity of the aminopeptidase activity, the hydrolysis of another natural peptide was explored. Kidney membranes were incubated with the Aplysia endogenous FMRFamide peptide and the metabolites analysed by reversedphase h.p.l.c. Synthetic markers and hydrolysis of FMRFamide by commercial aminopeptidase N were used to determine the position of major metabolites. Hydrolysis of FMRFamide by Aplysia kidney membranes revealed two peaks which co-migrated with the free N-terminal amino acid phenylalanine and the Cterminal MRFamide peptide (Figs. 4a, 4b and 4c ). This h.p.l.c. profile is identical with the degradation of FMRFamide by commercial mammalian aminopeptidase N (Fig. 4d) . These peaks were detected after an incubation period of 5 min (Fig. 4a ) and progressively increased with the reaction time (Figs. 4b and 4c) Taken together, these results indicate that the Aplysia aminopeptidase, like the mammalian aminopeptidase N, is not enkephalin-specific and can hydrolyse different peptides. Furthermore, the aminopeptidase activity is not restricted to the cleavage of the Tyr-Gly bond, since other N-terminal amino acids can be cleaved by this enzyme (see also below).
Degradation of p-nitroanilide derivatives by Aplysia kidney aminopeptidase
To characterize the Aplysia aminopeptidase activity further, two other substrates often used to study mammalian aminopeptidases were tested (Little et al., 1976; Amoscato et al., 1989) . As shown in Table 4 , both alanine-p-nitroanilide and leucine-pnitroanilide were hydrolysed by Aplysia kidney membranes. A similar activity was also observed with rat kidney membranes and with purified aminopeptidase N. The degradation of these substrates was inhibited by the aminopeptidase inhibitor amastatin at 10 /M, at a level comparable with the one found for the inhibition of [Leu] Aplysia kidney showed the presence of a peak of radioactive metabolites which co-migrated with free tyrosine (Fig. 5b) . Identical results were obtained with the membrane-bound activity from ovotestis and head ganglia. These results indicate that, in contrast with mammalian aminopeptidase N, the D-enantiomer of alanine could not completely protect the substrate from degradation by the Aplysia aminopeptidase and consequently did not allow us to detect other peptide-degrading enzymes. Hydrolysis of [3H][D-Ala2-Leu]enkephalin with membranes from rat kidney under the same conditions produced a single radioactive metabolite co-migrating with the tripeptide Tyr-D-Ala-Gly (not shown). This metabolite resulted from degradation of the substrate by neutral endopeptidase (Llorens et al., 1982) ; this activity was sensitive to neutral endopeptidase inhibitors (not shown).
This interesting point that the enzyme can cleave a peptide with a dextrorotatory amino acid has been extended by examining by reversed-phase h.p.l.c. the hydrolysis of dFMRFamide and FdMRFamide. In competition assays, both substrates inhibited 83-96 % of the hydrolysis of [3H][Leu]enkephalin by the aminopeptidase activity, showing that they are both recognized by the membrane-bound aminopeptidase. Under the same conditions as those used for the hydrolysis of FMRFamide (see above), we showed that dFMRFamide can be cleaved by the aminopeptidase activity in the kidney membranes (Fig. 5c) , suggesting that an N-terminal dextrorotatory amino acid does not protect the peptide from hydrolysis in Aplysia kidney. On the other hand, FdMRFamide, a peptide with a penultimate Dmethionine, was poorly cleaved (Fig. 5d) (Dyer et al., 1990; Hui et al., 1988;  McLellan et al. Mantle et al., 1990) . Both membranebound and cytosolic forms described in this paper have, however, a different inhibitor profile from a leucine aminopeptidase-like enzyme described in Aplysia haemolymph (Squire et al., 1991 (Payza, 1987) . Removal of the N-terminal amino acid by an aminopeptidase would provide a means of terminating the action of this peptide, by decreasing its affinity for the receptor. Oxidation of the penultimate methionine might be an alternative inactivation mechanism in FMRFamide-mediated neurotransmission (Price, 1986; Brussaard et al., 1989) . Other peptides, such as those involved in the regulation of renal, neuronal and/or reproductive functions, may also be good substrates for peptidases in Aplysia. Indeed, it has been shown that Aplysia pedal peptide, a peptide involved in locomotion, is rapidly degraded after release by peptidases present in haemolymph and foot tissues (Hall & Lloyd,. 1990) .
When used at a concentration of 0.1 mm, neutral endopeptidase inhibitors (phosphoramidon, thiorphan and HACBO-Gly) inhibited up to 50 % of the aminopeptidase activity. This result shows that a modification in physiological phenomenon or cellular behaviour after treatment in vivo with neutral endopeptidase inhibitors should be interpreted with caution when high concentrations of these inhibitors are used and especially if the metabolites are not characterized, as in the previous study by Shipp et al. (1990) . Surprisingly the enzyme from Aplysia was able to hydrolyse substrates known to be resistant to mammalian aminopeptidases because of the presence of a dextrorotatory amino acid (this work; Pert et al., 1976; Llorens et al., 1982) . We do not know the significance of the cleavage next to a dextrorotatory amino acid. This characteristic may be a vestige of evolution since dextrorotatory amino acid enantiomers are found in fungi and bacteria (Grafstein, 1983 (Grafstein, , 1984 . On the other hand, this enzyme could be involved in the physiological degradation of a still unknown molluscan peptide containing such an amino acid. In this respect, it is noteworthy that dermorphin, an active peptide containing a penultimate D-alanine (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-amide) has been described in frog skin (Montecucchi et al., 1981; Melchiorri etal., 1984) .
The identification of the physiologically relevant peptides in Aplysia can, however, only come from pharmacological studies using specific inhibitors for potentiating the biological activity of these peptides. These studies will be important for determining the biological implications of proteinases in controlling peptidemediated phenomena in the simple integrated model of peptidergic pathways provided by this mollusc.
